CELLSEARCH ASSAY HCPCS

May 24, 12
Other articles:
  • Circulating Tumor Cells (CTC) for Breast Cancer by CellSearch, Blood.
  • The results of a CellSearch™ test should be interpreted with caution if specimens
  • Guidelines for clinical use of the antinuclear antibody test and tests for specific
  • 877.225.7284 TEST MENU . . CPT Code(s): 88346 x 4, 88361 x 2 . Clinical
  • CPT Statement · Profile Statement. Circulating Tumor Cells (CTC). CellSearch™
  • Geisinger Medical Laboratories Test Catalog . OR CPT Code: CELLSEARCH (
  • Inadequate or delayed mixing may result in inaccurate test results. . (The CPT
  • The CellSearch™ system (Veridex) is an example of immunofluorescent . There
  • Circulating Tumor Cells (CTC) for Colorectal Cancer by CellSearch, Blood .
  • The CellSearch™ system (Veridex) is an example of immunofluorescent
  • Roche Diagnostics' AmpliChip CYP450 test, a microarray-based test to .
  • the performance characteristics of the CellSearch assay have been best studied.
  • HCPCS. COVERAGE STATUS. Actigraphy Testing, recording, analysis .
  • CellSearch Information Name: CellSearch™ Circulating Tumor Cells, Breast
  • Search Test List . (Test Code 29385Z , 4491) and by heat denaturation (Test
  • May 15, 2011 . Although not intended to replace imaging, CellSearch results may supplement .
  • Health Net, Inc. considers the Oncotype DX assay investigational and . .
  • Apr 1, 2012 . Carotid artery stenting. CPT (0075T, 0076T, 37215, 37216). Y. Y. Y. Cellsearch
  • A convenient DNA blood test that aids in the detection of colorectal cancer (CRC)
  • Feb 15, 2011 . mixtures were subjected to the CellSearch test to isolate the breast cancer . ..
  • Feb 17, 2012 . CPT is a registered trademark of the American Medical Association . .. The
  • appropriate HCPCS code below: S3711 Circulating tumor cell test. Also Known
  • May 19, 2011 . The CellSearch™ System (Veridex, LLC, Warren, New Jersey) is an example of
  • Jun 18, 2011 . CTC testing per the CellSearch® assay can be covered for patients with . The
  • Test Code. CellSearch. Specimen Requirements. Collect two tubes, 10 mL (min.
  • Enter CPT/HCPCS code, first three digits of an ICD-9-CM code or keyword in
  • The CellSearch™ system (Veridex) is an example of immunofluorescent
  • CellSearch™ technology (Veridex LLC). . Note: Antibodies used in the
  • LCD for Circulating Tumor Cell Marker Assays (L31703) . The CellSearch assay
  • CELLSEARCH. Synonyms: Circulating Tumor Cells. Lab Test Code: ZCELLB –
  • Jan 1, 2012 . (CPT) code changes to the 2012 edition of the CPT coding manual. .
  • Browse by Test Name: . Communiqué: The CellSearch Assay for Circulating
  • April 2011. Dr. Halling will provide an overview of the metastatic process in
  • The FDA-approved Veridex LLC CellSearch Circulating Tumor Cell Kit is
  • Implemented promotional programs positioning CellSearch® as a biomarker in
  • Apr 1, 2012 . CPT codes, descriptions and other . The assay is reported as a numerical result
  • This coverage policy is for the CellSearch® (Veridex) Circulating Tumor Cell (
  • Test Usage: As an aid in monitoring patients with metastatic breast cancer. Test
  • The CellSearch™ System (Veridex) is an example of immunofluorescent
  • Antibodies used in the CellSearch assay are targeted at cell markers (EpCAM
  • The CellSearch ® Circulating Tumor Cell (CTC) Test from Veridex is a simple
  • A test that detects autoantibodies to mutated citrullinated . A test that measures
  • Feb 17, 2011 . CYP2C19 Genotyping - Update test name and CPT coding. Remove .
  • Not required; CPT Code: 88361x2; LOINC Code: 19146-0; 19146-0; Ref Lab Test
  • Jun 18, 2010 . assays have not shown reproducible clinical value (re- . dition, study of such ''
  • Secondary ID A test code used for billing and in test definitions created prior to .
  • Journal of Clinical Oncology 23: 1420-1430. CellSearch Information. Name:
  • This product includes CPT which is commercial technical data and/or computer
  • Comments Blood from this test cannot be drawn through the IV line in which the
  • The limitation of the Circulating Tumor Cell Assay to the three disease states . At

  • Sitemap